To place a classified advertisement please contact: Lauren Bernick lbernick@ijpc.com or 405-513-4236

Editorial: Student Pharmacist Compounding Competition

This competition is growing in popularity and participation every year. Please read the following announcement and encourage your pharmacy students to participate.

MEDISCA is proud to launch the fourth Student Pharmacist Compounding Competition (SPCC). This event is an astounding learning experience where the student pharmacists bring forth a sense of pride and prestige to themselves and their college by promoting excellence and expertise in the field of pharmacy compounding.

The National SPCC is scheduled for March 22nd and 23rd, 2014 at the University of Florida College of Pharmacy in Gainesville, Florida. MEDISCA welcomes all pharmacy students, pharmacy school faculty members, and leaders in the compounding industry to take part in an event that lends itself to the development and integrity of the compounding industry.

For more information regarding the upcoming SPCC 2014 event, send communications to spcc@medisca.com or visit http://spcc.medisca.com.


Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition

J&J-Boehringer Dispute May Cause Doxil Shortage
J&J has announced that a dispute with Boehringer Ingelheim GmbH to produce Doxil may create a year-long shortage of the drug. One of Boehringer's U.S. units plans to shut down production of Doxil at year's end even though it still owes J&J 67 batches. Because of disruptions at the Boehringer plant where the drug is made, J&J has struggled to meet demand for the drug. Efforts implemented over the past 20 months to boost Doxil supplies using other manufacturers have fallen short, as those companies won't be able to win regulatory approval to make the drug until late 2014.

The Doxil shortage will again cause serious disruption and harm to hospitals, physicians, and patients. It is unknown when the drug will be available again in the U.S. The facility produced only seven of 31 batches expected this year after being forced to shut down production lines twice because of mold problems and a roof leak. Boehringer informed J&J in July that they would be cutting off Doxil production by December 31 and that they would not make up any deficient production before winding down its manufacturing operations.
http://www.bloomberg.com/news/2013-10-01/j-j-says-boehringer-doxil-dispute-may-cause-shortage.html

Compounding Pharmacies May Supply Execution Drugs
Ohio officials may soon release a new death-penalty protocol that could rely on compounding pharmacies for supplies of drug to be used in executions, says officials of the Ohio Department of Rehabilitation and Correction. Already, other states that perform executions (Texas just this week, Georgia recently, and Colorado, Pennsylvania, and South Dakota) have turned to the compounding pharmacies.
http://www.dispatch.com/content/stories/local/2013/10/03/compounding-pharmacies-might-make-execution-drug.html

Become a fan of the IJPC Facebook page and share ideas, photos, and keep up to date with the latest compounding information - http://www.facebook.com/IJPCompounding

�that tens of thousands of pumpkins are wasted every year by placing on yards, etc. as decorations? Some of these also end up "splatted" on the street during trick-or-treat activities. This is a lot of perfectly good food that is wasted.

Work with your community to encourage the use of other types of displays and purchase and donate the pumpkins to those that are in need of food.

Old Dobbin reads these
Signs each day,
You see, he gets
His corn that way!
      Burma Shave

Wanted: Repeater Pump
Looking to purchase a BAXA Repeater Pump New or Used
Call Russell @ 855-557-2683